slno,preds
0,"Here are the reasoning steps:

1. The patient has two distinct adenocarcinomas in the lung, both with free margins and no lymph node metastasis, which suggests that the cancer is localized and has not spread to other parts of the body.
2. The molecular studies revealed a positive KRAS mutation, which is associated with poor prognosis. This suggests that the patient's cancer may be more aggressive and have a worse outcome.
3. However, the patient's cancer is morphologically distinct, suggesting that it may represent separate primary cancers. This could potentially affect the prognosis, as the patient may have a better outcome due to the presence of two separate tumors rather than a single, more aggressive tumor.

Based on these factors, I would conclude that the patient's survival after 2.48 years is uncertain. While the patient's cancer is localized and has not spread to other parts of the body, the presence of a KRAS mutation suggests that the cancer may be more aggressive and have a worse outcome.

Answer: {""Survival"": ""Uncertain""}"
1,"Here are the reasoning steps:

1. The patient has a diagnosis of lung cancer, specifically a moderately differentiated adenocarcinoma.
2. The tumor is staged as T2N0, indicating that it is 2 cm in size and has not spread to the lymph nodes.
3. There is focal pleural invasion, but no lymphovascular space invasion.
4. All biopsied lymph nodes were negative for neoplasm, with some showing anthracotic pigment and reactive changes.

Based on these findings, the patient's prognosis is generally good. The tumor is localized and has not spread to the lymph nodes, which is a good sign. The presence of focal pleural invasion is a concern, but it is not a major predictor of survival.

Therefore, the answer is:

{""Survival"": ""True""}"
2,"Here are the reasoning steps:

1. The patient underwent a left lower lobectomy, which suggests that the tumor was localized to the left lower lobe and was completely removed.
2. The tumor is well-differentiated, which indicates that it is less aggressive and has a better prognosis.
3. The tumor is minimally invasive, which means that it has not invaded deeply into the surrounding tissue.
4. The tumor has negative surgical margins, which means that there is no evidence of tumor cells at the edges of the resected tissue.
5. There is no evidence of lymphovascular invasion or visceral pleura invasion, which suggests that the tumor has not spread to the lymph nodes or the pleura.
6. The lymph node examinations from various sites showed no malignancy in the sampled nodes, which confirms that the tumor has not spread to the lymph nodes.

Based on these findings, the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
3,"Here are the reasoning steps:

1. The patient has a diagnosis of moderately-poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor size is relatively small, measuring 2.5 x 2.0 cm, which is a favorable factor.
3. However, the tumor has extensive lymphovascular invasion, which is a poor prognostic factor.
4. The most concerning finding is that 10 out of 12 lymph nodes are involved with metastatic carcinoma, including the subcarinal lymph node, which is a common site for lymph node metastasis.
5. The presence of lymph node metastasis indicates that the cancer has spread beyond the primary tumor site, which is a poor prognostic factor.
6. The surgical margins are negative for tumor, which is a favorable factor.
7. Considering the aggressive nature of the tumor, the extensive lymphovascular invasion, and the presence of lymph node metastasis, it is likely that the patient will not survive for 2.48 years.

Answer: {""Survival"": ""False""}"
4,"Here are the reasoning steps:

1. The patient has a diagnosis of invasive poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor is 2.7 cm in size, which is relatively large, and has invaded the visceral pleura, which is a poor prognostic factor.
3. The tumor also has intratumoral large vessel invasion, which is a sign of aggressive behavior.
4. The patient has a parenchymal margin of 8 mm, which is relatively small, indicating that the tumor is close to the edge of the resected lung tissue.
5. Despite the aggressive features of the tumor, the patient does not have any evidence of distant metastasis.

Based on these factors, I would conclude that the patient's prognosis is poor, and they are unlikely to survive for 2.48 years. Therefore, the answer is:

{""Survival"": ""False""}"
5,"Here are the reasoning steps:

1. The patient has a diagnosis of invasive mucinous adenocarcinoma, which is a type of lung cancer.
2. The tumor is 2.5 cm in size, which is relatively small.
3. The margins are clear, indicating that the tumor has been completely removed.
4. All examined lymph nodes are negative for carcinoma, indicating no regional lymph node metastasis.
5. The molecular studies revealed a positive KRAS mutation, which is a known predictor of poor prognosis and resistance to certain therapies.

Based on these findings, I would conclude that the patient has a relatively good prognosis, but the presence of a KRAS mutation suggests that the patient may have a poorer outcome compared to patients without this mutation.

Answer: {""Survival"": ""False""}"
6,"Here are the reasoning steps:

1. The patient has a diagnosis of invasive grade 3 adenocarcinoma, which is a high-grade tumor.
2. The tumor is positive for metastasis in one of six intrapulmonary peribronchial lymph nodes, indicating that the cancer has spread to the lymph nodes.
3. The patient has a pTNM stage of pT2 N1, which indicates that the tumor is 5 cm or larger in size and has spread to the lymph nodes.
4. The patient does not have any evidence of visceral pleural or lymphovascular invasion, which is a good prognostic factor.
5. The patient does not have any evidence of distant metastasis, as the lymph nodes from the inferior and superior mediastinum were negative for tumor.

Based on these factors, the patient's prognosis is poor. The high-grade tumor, lymph node metastasis, and pTNM stage all indicate a high risk of recurrence and poor survival.

Answer: {""Survival"": ""False""}"
7,"Here are the reasoning steps:

1. The pathology report indicates a diagnosis of moderately differentiated adenocarcinoma, which is a type of non-small cell lung cancer (NSCLC).
2. The tumor size is 2.3 cm, which is relatively small.
3. The tumor does not invade the visceral pleura, which is a good prognostic factor.
4. There is no evidence of metastatic carcinoma in the examined lymph nodes, which suggests that the disease is localized.
5. The final staging is pT1b N0, which indicates that the tumor is confined to the lung and has not spread to the lymph nodes.

Based on these factors, I would conclude that the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
8,"Here are the reasoning steps:

1. The patient has invasive moderately differentiated adenocarcinoma, which is a type of lung cancer.
2. The tumor has metastasized to one of four hilar lymph nodes, indicating that the cancer has spread beyond the primary tumor site.
3. However, the surgical margins, including the bronchial resection margin, are negative for carcinoma, indicating that the tumor has been completely removed.
4. There is no evidence of pleural involvement or angiolymphatic invasion, which suggests that the cancer has not spread to other parts of the body.
5. The presence of hyalinized granulomata in additional biopsies from various lymph nodes is not relevant to the patient's survival prognosis.

Based on these findings, I conclude that the patient has stage II lung cancer, which has a 5-year survival rate of around 40-50%. However, since the patient has undergone complete resection of the tumor, their survival prognosis is likely better than the average for stage II lung cancer.

Therefore, my answer is:

{""Survival"": ""True""}"
9,"Here are the reasoning steps:

1. The pathology report indicates an invasive well-differentiated adenocarcinoma with a predominant bronchiolo-alveolar carcinoma component, which suggests a relatively slow-growing tumor.
2. The tumor measures approximately 50 x 60 x 45 mm, which is a relatively large size, but the report does not indicate any evidence of vascular or perineural invasion, which are poor prognostic factors.
3. The tumor does not metastasize to hilar lymph nodes, which suggests that the cancer has not spread to distant sites.
4. Although the tumor closely abuts the pleural surface, confirmatory stains suggest that the pleura is likely not involved, which reduces the risk of pleural metastases.
5. The report also mentions a separate specimen from the back that shows features consistent with a lipoma, with no evidence of malignancy, which suggests that the patient does not have any other concurrent malignancies.

Based on these findings, I would conclude that the patient has a relatively good prognosis and is likely to survive after 2.48 years.

Answer - {""Survival"": ""True""}"
10,"Here are the reasoning steps:

1. The patient has a poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor has invaded the visceral pleura, which indicates that it has spread beyond the lung tissue.
3. The tumor has also metastasized to one of the examined lymph nodes, which suggests that the cancer has spread to other parts of the body.
4. The immunohistochemical staining results are positive for CD15, CK7, TTF1, and CEA, which are markers commonly associated with lung adenocarcinoma.
5. However, the staining results are negative for CK20 and CDX2, which are markers more commonly associated with other types of cancer.

Based on these findings, it is likely that the patient has a more advanced stage of lung cancer, with a higher risk of recurrence and poor prognosis.

Answer: {""Survival"": ""False""}"
11,"Here are the reasoning steps:

1. The patient has a tumor in the left lower lobe of the lung, measuring 4.0 x 3.5 x 2.0 cm, diagnosed as adenocarcinoma of mixed subtype, predominantly papillary.
2. The tumor has infiltrated the visceral pleura, which is a poor prognostic factor.
3. The tumor is classified as pT2, which indicates that it has invaded the lung tissue, but not the chest wall or diaphragm.
4. There is no regional lymph node involvement (0/20), which is a good prognostic factor.
5. The distant metastasis status is unknown (pMx), which means that the patient may or may not have metastases elsewhere in the body.
6. The tumor grade is G2, indicating moderate differentiation, which is a good prognostic factor.

Based on these factors, I would conclude that the patient has a moderate-risk lung cancer, with a potential for distant metastases. However, the lack of regional lymph node involvement and moderate differentiation suggest that the patient may have a better prognosis.

Answer: {""Survival"": ""True""}"
12,"Here are the reasoning steps:

1. The patient underwent a right upper lobe lobectomy, which suggests that the tumor was localized to the right upper lobe and did not spread to other parts of the lung.
2. The tumor is moderately differentiated adenocarcinoma, which is a more favorable prognosis compared to poorly differentiated adenocarcinoma.
3. There is no angiolymphatic invasion, which means that the tumor did not invade blood vessels or lymphatic vessels, which is a good sign.
4. The tumor did not involve the pleura, which is the lining surrounding the lung.
5. The bronchial margin is negative for tumor involvement, which means that the tumor did not spread to the bronchial tissue.
6. Metastatic adenocarcinoma was found in 1 out of 4 peribronchial lymph nodes, which suggests that the tumor had spread to the lymph nodes, but only to a limited extent.
7. No metastatic carcinoma was identified in the R4 and station 11 lymph nodes, which suggests that the tumor did not spread to other lymph nodes.

Based on these findings, the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
13,"Here are the reasoning steps:

1. The patient has a diagnosis of pulmonary adenocarcinoma, which is a type of non-small cell lung cancer (NSCLC).
2. The tumor size is 1.2 cm, which is relatively small.
3. The tumor is moderately to poorly differentiated, which suggests that it may have a worse prognosis.
4. There is focal invasion into the visceral pleura, which is a sign of local invasion.
5. There is also a focus suggestive of lymphatic invasion, which suggests that the tumor may have spread to the lymph nodes.
6. However, despite the presence of lymphatic invasion, there is no lymph node involvement detected among the seven examined lymph nodes.
7. The patient has not undergone further mutation analysis for EGFR and KRAS, which may guide potential targeted therapy options.

Based on these findings, I would conclude that the patient has a relatively early-stage NSCLC with a good prognosis. The fact that there is no lymph node involvement and the tumor is small suggests that the patient may have a high chance of survival.

Answer: {""Survival"": ""True""}"
14,"Here are the reasoning steps:

1. The patient has a diagnosis of adenocarcinoma, acinar type, grade III, which is a poorly differentiated tumor.
2. The tumor is 4 cm in size and invades the visceral pleura, indicating a higher stage tumor.
3. The tumor has metastasized to two of four lymph nodes examined, indicating regional lymph node involvement (N2).
4. The staging is pT2, N2, Mx, which indicates that the tumor is stage IIIB, with metastasis to regional lymph nodes.

Based on these findings, it is likely that the patient will not survive for 2.48 years. The presence of regional lymph node metastasis and the poorly differentiated nature of the tumor indicate a more aggressive disease.

Answer: {""Survival"": ""False""}"
15,"Here are the reasoning steps:

1. The patient has a large tumor size of 9.2 cm, which is a poor prognostic factor.
2. The tumor has invaded the chest wall, which is a sign of advanced disease.
3. The tumor has a pathological staging of pT3, which is also a poor prognostic factor.
4. There is no evidence of lymph node metastasis, which is a good prognostic factor.
5. The tumor is moderately differentiated, which is a relatively good prognostic factor.

Considering these factors, the patient's prognosis is poor due to the large tumor size, chest wall invasion, and advanced pathological staging. Therefore, the answer is:

{""Survival"": ""False""}"
16,"Here are the reasoning steps:

1. The patient has a diagnosis of lung adenocarcinoma with regional lymph node involvement, which indicates that the cancer has spread to the lymph nodes.
2. The tumor is moderately differentiated, which suggests that it may be more aggressive.
3. The tumor has visceral pleural invasion, which means that it has invaded the lining of the lung, which can make it more difficult to treat.
4. The tumor also has lymphangitic invasion, which means that it has invaded the lymphatic vessels, which can also make it more difficult to treat.
5. Despite the presence of regional lymph node involvement, there is no evidence of distant metastasis.

Based on these findings, it is likely that the patient will not survive for 2.48 years. The presence of regional lymph node involvement and visceral pleural invasion suggests that the cancer is more advanced and may be more difficult to treat.

Answer: {""Survival"": ""False""}"
17,"Reasoning steps:

1. The pathology report does not provide any specific diagnostic information about the case, including the type of tumor, its size, location, or any relevant histological features.
2. Without this information, it is impossible to determine the patient's prognosis or likelihood of survival after 2.48 years.
3. The report only provides instructions for completing a TCGA Missing Pathology Report Form, which suggests that the specimen was sent to the IGC Biospecimen Core Resource (BCR) for further analysis.
4. However, this information does not provide any relevant clinical or pathological data that would allow us to predict the patient's survival.

Answer: {""Survival"": ""Insufficient Information""}"
18,"Here are the reasoning steps:

1. The pathology report indicates a diagnosis of well-differentiated papillary non-mucinous adenocarcinoma, which is a less aggressive type of lung cancer.
2. The tumor is classified as stage I B, indicating that it is localized to the lung and has not spread to lymph nodes or distant sites.
3. The resection margins are clear of tumor, denoted as R0, which means that the entire tumor was removed during surgery and there is no evidence of residual disease.
4. There is no evidence of lymph node involvement (pN0) or distant metastasis (pMX).

Based on these findings, the patient is likely to survive for at least 2.48 years without evidence of recurrence or progression of the disease.

Answer: {""Survival"": ""True""}"
19,"Here are the reasoning steps:

1. The patient has a poorly differentiated adenocarcinoma with visceral pleural and lymphovascular invasion, which indicates an aggressive tumor behavior.
2. The tumor is present at the pleural surface, which suggests that it has already spread to the pleura, a common site for metastasis.
3. One of the six lymph nodes examined contains metastatic carcinoma with extracapsular extension, which indicates that the tumor has already spread to the lymph nodes and has broken through the capsule, allowing it to spread further.
4. The tumor is staged as pT2aN1MX, which indicates that it has spread to the lymph nodes (N1) and has distant metastasis (MX).

Based on these findings, it is likely that the patient will not survive for 2.48 years. The tumor has already spread to the lymph nodes and has distant metastasis, which indicates a poor prognosis.

Answer: {""Survival"": ""False""}"
20,"Here are the reasoning steps:

1. The pathology report describes a poorly differentiated bronchiolo-alveolar adenocarcinoma, which is a type of lung cancer.
2. The tumor size is 2.5 x 1.5 x 3 cm, which is a moderate-sized tumor.
3. There is no information provided about the tumor's extent, other nodules, lymph nodes, or invasion, which makes it difficult to determine the stage of the cancer.
4. The report does not mention any positive lymph nodes, which suggests that the cancer may not have spread to the lymph nodes.
5. However, the lack of information about the tumor's extent and invasion makes it difficult to determine the patient's prognosis.

Based on the limited information provided, it is difficult to determine the patient's survival rate. However, I will provide an answer based on the available information.

Answer - {""Survival"": ""Unknown""}"
21,"Here are the reasoning steps:

1. The patient has a moderately-differentiated adenocarcinoma, which is a more favorable histology compared to poorly differentiated or undifferentiated tumors.
2. The tumor is 2.5 cm in size, which is relatively small and may be associated with a better prognosis.
3. The margins are negative, indicating that the tumor has been completely resected, which is a positive factor.
4. There is no evidence of vascular or lymphatic invasion, which suggests that the tumor has not spread to distant sites.
5. All examined regional lymph nodes and the fat pad biopsy were negative for malignancy, indicating that the tumor has not metastasized to the lymph nodes.
6. The tumor shows invasion towards the pleural surface, but does not directly involve the visceral pleura, which suggests that the tumor has not spread to the pleura.

Based on these factors, I would conclude that the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
22,"Here are the reasoning steps:

1. The pathology report indicates the presence of metastatic carcinoma in multiple lymph nodes, which suggests that the cancer has spread beyond the primary tumor site.
2. The tumor size is approximately 1.7 cm, which is relatively small, but the presence of lymphatic invasion and capsular penetration indicates that the cancer has invaded the surrounding tissue.
3. The surgical margins are negative for carcinoma, which suggests that the tumor has not spread to the surrounding tissue, but the presence of metastatic carcinoma in multiple lymph nodes indicates that the cancer has already spread to other parts of the body.
4. The findings are consistent with a pulmonary primary, excluding breast carcinoma as the source of the metastasis, which suggests that the primary tumor is located in the lung.

Based on these findings, it is likely that the patient will not survive after 2.48 years. The presence of metastatic carcinoma in multiple lymph nodes and the evidence of lymphatic invasion and capsular penetration indicate that the cancer has already spread to other parts of the body, which is a poor prognostic factor.

Answer: {""Survival"": ""False""}"
23,"Here are the reasoning steps:

1. The patient has a localized lung adenocarcinoma, meaning the tumor is confined to the lung and has not spread to other parts of the body.
2. The tumor is moderately differentiated, which suggests that it is not highly aggressive.
3. The surgical margins are clear, indicating that the tumor has been completely removed.
4. There is no pleural involvement, which means the tumor has not spread to the lining of the lung.
5. The lymph nodes from various levels are negative for malignancy, indicating that the tumor has not spread to the lymph nodes.

Based on these findings, it is likely that the patient will survive for at least 2.48 years without the tumor spreading to other parts of the body.

Answer: {""Survival"": ""True""}"
24,"Here are the reasoning steps:

1. The patient has a diagnosis of adenocarcinoma (not otherwise specified) in the left upper lobe of the lung.
2. The tumor size is 6.5 x 6.5 x 5.0 cm, which is a relatively large tumor.
3. The tumor has invaded the lymph nodes (pN1), which indicates regional lymph node involvement.
4. The tumor is classified as pT2b, which indicates that it has invaded the lung tissue beyond the primary tumor site.
5. The tumor is classified as G3, which indicates that it is poorly differentiated.
6. The immunohistochemical analysis shows that the tumor cells are positive for CK7 and have a Ki-67 proliferation index of 40%, which suggests that the tumor is aggressive.

Based on these findings, it is likely that the patient will not survive for 2.48 years. The tumor is large, has invaded the lymph nodes, and is poorly differentiated, which suggests that it is likely to be aggressive and have a poor prognosis.

Answer: {""Survival"": ""False""}"
25,"Here are the reasoning steps:

1. The patient has metastatic adenocarcinoma, which means the cancer has spread beyond the primary tumor site.
2. Eight out of twelve lymph nodes from the left lung show positive results for cancer, indicating widespread metastasis.
3. The tumor is moderately to poorly differentiated, which suggests a more aggressive behavior.
4. The presence of lymphovascular invasion and direct extension into two intraparenchymal lymph nodes further supports the aggressive nature of the tumor.
5. The molecular analysis for EGFR mutations was negative, which may impact treatment options, but does not directly affect the patient's survival prognosis.

Based on these findings, it is likely that the patient will not survive for 2.48 years. The widespread metastasis, aggressive tumor behavior, and lack of effective targeted therapy options suggest a poor prognosis.

Answer: {""Survival"": ""False""}"
26,"Here are the reasoning steps:

1. The patient has a diagnosis of invasive adenocarcinoma, which is a type of lung cancer.
2. The tumor is classified as pT2a, which means it is a tumor that is 2 cm or less in size and has not invaded the visceral pleura or large vessels.
3. The tumor has also invaded one lymph node (hilar node #2), which is classified as pN1.
4. The resection margins are clear of tumor, which means that the surgeon removed the entire tumor and there is no evidence of remaining cancer cells.
5. The patient's TNM stage is pT2a, pN1, pMX, which indicates that the tumor is stage II, with a moderate level of lymph node involvement.

Based on these findings, the patient's prognosis is likely to be good, with a high chance of survival. However, the patient will likely require further treatment, such as chemotherapy and/or radiation therapy, to reduce the risk of recurrence.

Answer: {""Survival"": ""True""}"
27,"Here are the reasoning steps:

1. The pathology report indicates the presence of metastatic adenocarcinoma in peribronchial lymph nodes, which suggests that the cancer has spread beyond the primary tumor site.
2. The tumor invades the visceral pleura, which is a sign of local invasion.
3. There is no evidence of vascular invasion, which is a good sign.
4. Lymphatic invasion is pending, but even if it is positive, it would not change the overall prognosis.
5. The presence of centrilobular emphysema, pulmonary hemosiderosis, and necrotizing granulomas in the lymph nodes is not directly related to the patient's survival.
6. The tumor has a size of 3.5 x 2.8 x 2.5 cm, which is relatively large.

Based on these findings, I conclude that the patient is unlikely to survive after 2.48 years. The presence of metastatic disease in lymph nodes and local invasion of the visceral pleura are strong indicators of poor prognosis.

Answer: {""Survival"": ""False""}"
28,"Here are the reasoning steps:

1. The patient has a poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor is 58 mm in size, which is relatively large.
3. The tumor has visceral pleural invasion, which means it has invaded the lining of the lung, and has also invaded the chest wall.
4. There is evidence of blood vessel invasion, which can lead to distant metastasis.
5. However, there is no lymphatic or perineural invasion, which is a good sign.
6. No lymph node metastases were found, which is also a good sign.
7. The tumor is clear of the bronchial resection margin, which means the surgeon was able to remove the tumor completely.

Considering these factors, I would conclude that the patient's prognosis is poor. The tumor is large, has invaded surrounding tissues, and has blood vessel invasion, which increases the risk of distant metastasis. However, the fact that there is no lymphatic or perineural invasion, and no lymph node metastases, suggests that the tumor may not have spread as far as it could have.

Based on this analysis, I would select answer:

{""Survival"": ""False""}"
29,"Here are the reasoning steps:

1. The pathology report indicates a diagnosis of poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor size is 3.5 x 3 cm, which is relatively small.
3. There is no evidence of venous invasion, which is a good sign.
4. All 7 hilar lymph nodes examined were negative for metastasis, indicating that the cancer has not spread to the lymph nodes.
5. The surgical margins are uninvolved, suggesting that the tumor was completely resected.

Based on these findings, I would conclude that the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
30,"Here are the reasoning steps:

1. The patient has a Stage IIB lung adenocarcinoma, which is an early stage of cancer.
2. The tumor is 3.7 cm in size, which is relatively small.
3. There is no visceral pleural invasion or lymph-vascular invasion, which suggests that the cancer has not spread to other parts of the body.
4. All examined lymph nodes (11 total) are negative for cancer, indicating that the cancer has not metastasized to the lymph nodes.
5. Ancillary studies show no EGFR mutations detected, which suggests that the cancer is not driven by a specific genetic mutation.

Based on these findings, the patient has a good prognosis and is likely to survive for at least 2.48 years.

Answer: {""Survival"": ""True""}"
31,"Here are the reasoning steps:

1. The patient has a diagnosis of non-small cell carcinoma, specifically adenocarcinoma, poorly differentiated, which is an aggressive type of lung cancer.
2. The tumor size is 3.5 cm, which is considered large and may indicate a higher risk of recurrence and metastasis.
3. The tumor has invaded into visceral pleura and large vessels, which suggests that the cancer has spread beyond the primary tumor site.
4. Regional lymph nodes showed metastases in the ipsilateral peribronchial and hilar lymph nodes, which indicates that the cancer has spread to the lymph nodes.
5. However, multiple lymph node biopsies from various stations were negative for malignancy, which suggests that the cancer has not spread to other parts of the body.
6. The bronchial margins were reported as free of tumor, with a distance of 5 mm from the invasive carcinoma to the closest margin, which suggests that the surgery was able to remove the tumor with a clear margin.

Based on these findings, I would conclude that the patient has a high risk of recurrence and metastasis due to the aggressive nature of the tumor and the presence of lymph node metastases. Therefore, I would predict that the patient will not survive after 2.48 years.

Answer: {""Survival"": ""False""}"
32,"Here are the reasoning steps:

1. The patient has a poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor is 2.5 cm in size, which is considered a moderate-sized tumor.
3. The surgical margins are uninvolved, which means that the tumor has not spread to the surrounding tissue.
4. There is a suggestion of visceral pleural invasion, which means that the tumor has invaded the lining of the lung.
5. The right lower lobe lobectomy showed no residual malignancy, which means that the tumor has been completely removed.
6. Two lymph nodes from the specimen were negative for metastatic disease, which means that the tumor has not spread to the lymph nodes.
7. However, the level 12 nodes demonstrated evidence of metastasis, which means that the tumor has spread to the lymph nodes in that area.

Based on these findings, I would conclude that the patient has a high risk of recurrence and may not survive after 2.48 years.

Answer: {""Survival"": ""False""}"
33,"Here are the reasoning steps:

1. The patient has a poorly differentiated adenocarcinoma, which is an aggressive type of lung cancer.
2. The tumor invades the pleura, which is a poor prognostic factor.
3. Vascular invasion is also present, which increases the risk of distant metastasis.
4. There is no evidence of regional lymph node involvement or distant metastasis noted in the report, but this does not necessarily mean that the patient does not have metastatic disease.
5. The patient's tumor is not staged, but based on the pathology report, it is likely to be stage IV due to the presence of vascular invasion.

Given these factors, it is likely that the patient will not survive after 2.48 years.

Answer: {""Survival"": ""False""}"
34,"Here are the reasoning steps:

1. The patient has a stage T2N0MX, which means the tumor is 2.8 cm in size, has invaded the visceral pleura and angiolymphatic structures, but has not metastasized to lymph nodes.
2. The surgical resection margins are free of tumor, indicating that the tumor has been completely removed.
3. There is no evidence of distant metastasis (MX).
4. The tumor is moderately differentiated, which is a favorable prognostic factor.
5. The patient has chronic inflammation and submucosal scarring in the respiratory mucosa, which may be a sign of chronic lung disease, but it is not a direct indicator of survival.
6. The patient has background emphysematous changes in the lung, which may be a sign of chronic lung disease, but it is not a direct indicator of survival.

Based on these factors, I would conclude that the patient has a good prognosis and is likely to survive after 2.48 years.

Answer: {""Survival"": ""True""}"
35,"Here are the reasoning steps:

1. The pathology report indicates a diagnosis of poorly differentiated non-small cell carcinoma, which is a broad category that includes several subtypes of lung cancer.
2. The report notes that the tumor is positive for TTF-1 and negative for p63, CK5/6, CK7, and CK20, which suggests that the tumor is likely an adenocarcinoma.
3. The report also notes that all examined lymph nodes were negative for carcinoma, which suggests that the tumor has not metastasized to the lymph nodes.
4. The report mentions that further characterization of the tumor type is pending additional immunoevaluation, which suggests that the tumor type is not yet fully determined.

Based on these findings, it is likely that the patient will survive after 2.48 years. The tumor is poorly differentiated, but it has not metastasized to the lymph nodes, which is a good prognostic sign. Additionally, the tumor is likely an adenocarcinoma, which is a more indolent subtype of lung cancer compared to squamous cell carcinoma.

Answer: {""Survival"": ""True""}"
36,"Here are the reasoning steps:

1. The patient underwent a right lung pneumonectomy, which suggests that the tumor was completely removed.
2. The tumor was poorly differentiated adenocarcinoma with clear cell changes, but it did not invade the visceral pleura, which is a good sign.
3. The bronchial and vascular margins were negative for tumor, indicating that the tumor was completely removed with clear margins.
4. All examined lymph nodes from levels 4, 7, and 9, as well as a portion of the sixth rib, showed no evidence of tumor, suggesting that there was no metastatic spread to the lymph nodes.

Based on these findings, it is likely that the patient will survive after 2.48 years. The tumor was completely removed with clear margins, and there was no evidence of metastatic spread to the lymph nodes. Therefore, the answer is:

{""Survival"": ""True""}"
37,"Here are the reasoning steps:

1. The pathology report indicates that the patient has a mixed acinar and bronchioloalveolar adenocarcinoma, which is a type of non-small cell lung cancer (NSCLC).
2. The tumor is moderately to poorly differentiated, which suggests that it may have a worse prognosis.
3. The tumor has metastasized to one of two resected lymph nodes, which indicates that the cancer has spread beyond the primary tumor site.
4. The KRAS mutation analysis is positive, which suggests that the patient may have a worse prognosis due to the presence of a KRAS mutation.

Based on these factors, it is likely that the patient will not survive after 2.48 years.

Answer: {""Survival"": ""False""}"
